USPTO serial 88344838
ADAPTDX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, REBECCA A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ADAPTDX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Hoang-chi Truong
Hoang-chi Truong PATENT LAW WORKS LLP310 East 4500 South, Suite 400Salt Lake City, UT 84107UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Immunosequencing-based assay kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for detection of cancer, autoimmune disease and infection; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune disease and infection; the aforementioned goods not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment | ACTIVE | — |
| 042 | Medical laboratory services; the aforementioned services not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment | ACTIVE | — |
| 044 | Providing medical diagnostic and prognostic testing for cancer, autoimmune disease and infection, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; medical services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; the aforementioned services not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Adaptive Biotechnologies Corporation
- Other trademarks owned by Adaptive Biotechnologies Corporation
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ADAPTDX
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 25, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 25, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 24, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 22, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 22, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 22, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 17, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 15, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 15, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 15, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 24, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 23, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 20, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 3, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 2, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 2, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 4, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 4, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 28, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 21, 2019 | NWAP | NEW APPLICATION ENTERED | — |